APO Research
Talk to an analyst

APO RESEARCH · REPORT

Overactive Bladder Treatment

Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device.

Selected research

Market Structure

Global Overactive Bladder Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

9 January 2026180 pages

Choose your research edition.

Industry ResearchOveractive Bladder Treatment Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Overactive Bladder Treatment Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Overactive Bladder Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Overactive Bladder Treatment Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Overactive Bladder Treatment Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device.

Global Overactive Bladder Treatment key players include Allergan, Astellas Pharma, Pfizer, Johnson & Johnson, Medtronic, etc. Global top five manufacturers hold a share about 90%. United States is the largest market, with a share about 60%, followed by Europe, with a share about 15 percent. In terms of product, Drugs is the largest segment, with a share about 95%. And in terms of application, the largest application is Idiopathic Overactive Bladder, followed by Neurogenic Overactive Bladder.

Report Includes

Read the full market overview

This report provides an overview of the global Overactive Bladder Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Overactive Bladder Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Overactive Bladder Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Overactive Bladder Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Overactive Bladder Treatment Segment by Company

Allergan

Astellas Pharma

Pfizer

Johnson & Johnson

Medtronic

KYORIN Pharmaceutical

Overactive Bladder Treatment Segment by Type

Drugs

Device

Overactive Bladder Treatment Segment by Application

Idiopathic Overactive Bladder

Neurogenic Overactive Bladder

Overactive Bladder Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Overactive Bladder Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Overactive Bladder Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Overactive Bladder Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Overactive Bladder Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Overactive Bladder Treatment industry.

Chapter 3: Detailed analysis of Overactive Bladder Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Overactive Bladder Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Overactive Bladder Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Drugs Table 3. Key Players of Device Table 4. Global Overactive Bladder Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Idiopathic Overactive Bladder Table 6. Key Players of Neurogenic Overactive Bladder Table 7. Global Overactive Bladder Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Overactive Bladder Treatment Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Overactive Bladder Treatment Market Share by Region (2021-2026) Table 10. Global Overactive Bladder Treatment Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Overactive Bladder Treatment Market Share by Region (2027-2032) Table 12. Overactive Bladder Treatment Industry Trends Table 13. Overactive Bladder Treatment Industry Drivers Table 14. Overactive Bladder Treatment Industry Opportunities and Challenges Table 15. Overactive Bladder Treatment Industry Restraints Table 16. Global Overactive Bladder Treatment Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Overactive Bladder Treatment Revenue Market Share by Company (2021-2026) Table 18. Global Overactive Bladder Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Overactive Bladder Treatment Key Company Head Office and Area Served Table 20. Global Overactive Bladder Treatment Company, Product Type & Application Table 21. Global Overactive Bladder Treatment Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Overactive Bladder Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Overactive Bladder Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Overactive Bladder Treatment Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Overactive Bladder Treatment Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Overactive Bladder Treatment Revenue Market Share by Type (2021-2026) Table 28. Global Overactive Bladder Treatment Revenue Market Share by Type (2027-2032) Table 29. Global Overactive Bladder Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Overactive Bladder Treatment Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Overactive Bladder Treatment Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Overactive Bladder Treatment Revenue Market Share by Application (2021-2026) Table 33. Global Overactive Bladder Treatment Revenue Market Share by Application (2027-2032) Table 34. Allergan Company Information Table 35. Allergan Business Overview Table 36. Allergan Overactive Bladder Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Allergan Overactive Bladder Treatment Product Portfolio Table 38. Allergan Recent Development Table 39. Astellas Pharma Company Information Table 40. Astellas Pharma Business Overview Table 41. Astellas Pharma Overactive Bladder Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Astellas Pharma Overactive Bladder Treatment Product Portfolio Table 43. Astellas Pharma Recent Development Table 44. Pfizer Company Information Table 45. Pfizer Business Overview Table 46. Pfizer Overactive Bladder Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Pfizer Overactive Bladder Treatment Product Portfolio Table 48. Pfizer Recent Development Table 49. Johnson & Johnson Company Information Table 50. Johnson & Johnson Business Overview Table 51. Johnson & Johnson Overactive Bladder Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Johnson & Johnson Overactive Bladder Treatment Product Portfolio Table 53. Johnson & Johnson Recent Development Table 54. Medtronic Company Information Table 55. Medtronic Business Overview Table 56. Medtronic Overactive Bladder Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Medtronic Overactive Bladder Treatment Product Portfolio Table 58. Medtronic Recent Development Table 59. KYORIN Pharmaceutical Company Information Table 60. KYORIN Pharmaceutical Business Overview Table 61. KYORIN Pharmaceutical Overactive Bladder Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. KYORIN Pharmaceutical Overactive Bladder Treatment Product Portfolio Table 63. KYORIN Pharmaceutical Recent Development Table 64. North America Overactive Bladder Treatment Market Size by Type (2021-2026) & (US$ Million) Table 65. North America Overactive Bladder Treatment Market Size by Type (2027-2032) & (US$ Million) Table 66. North America Overactive Bladder Treatment Market Size by Application (2021-2026) & (US$ Million) Table 67. North America Overactive Bladder Treatment Market Size by Application (2027-2032) & (US$ Million) Table 68. North America Overactive Bladder Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 69. North America Overactive Bladder Treatment Market Size by Country (2021-2026) Table 70. North America Overactive Bladder Treatment Market Size by Country (2027-2032) Table 71. Europe Overactive Bladder Treatment Market Size by Type (2021-2026) & (US$ Million) Table 72. Europe Overactive Bladder Treatment Market Size by Type (2027-2032) & (US$ Million) Table 73. Europe Overactive Bladder Treatment Market Size by Application (2021-2026) & (US$ Million) Table 74. Europe Overactive Bladder Treatment Market Size by Application (2027-2032) & (US$ Million) Table 75. Europe Overactive Bladder Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. Europe Overactive Bladder Treatment Market Size by Country (2021-2026) Table 77. Europe Overactive Bladder Treatment Market Size by Country (2027-2032) Table 78. China Overactive Bladder Treatment Market Size by Type (2021-2026) & (US$ Million) Table 79. China Overactive Bladder Treatment Market Size by Type (2027-2032) & (US$ Million) Table 80. China Overactive Bladder Treatment Market Size by Application (2021-2026) & (US$ Million) Table 81. China Overactive Bladder Treatment Market Size by Application (2027-2032) & (US$ Million) Table 82. Asia Overactive Bladder Treatment Market Size by Type (2021-2026) & (US$ Million) Table 83. Asia Overactive Bladder Treatment Market Size by Type (2027-2032) & (US$ Million) Table 84. Asia Overactive Bladder Treatment Market Size by Application (2021-2026) & (US$ Million) Table 85. Asia Overactive Bladder Treatment Market Size by Application (2027-2032) & (US$ Million) Table 86. Asia Overactive Bladder Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Asia Overactive Bladder Treatment Market Size by Country (2021-2026) Table 88. Asia Overactive Bladder Treatment Market Size by Country (2027-2032) Table 89. South America, Middle East & Africa Overactive Bladder Treatment Market Size by Type (2021-2026) & (US$ Million) Table 90. South America, Middle East & Africa Overactive Bladder Treatment Market Size by Type (2027-2032) & (US$ Million) Table 91. South America, Middle East & Africa Overactive Bladder Treatment Market Size by Application (2021-2026) & (US$ Million) Table 92. South America, Middle East & Africa Overactive Bladder Treatment Market Size by Application (2027-2032) & (US$ Million) Table 93. South America, Middle East & Africa Overactive Bladder Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. South America, Middle East & Africa Overactive Bladder Treatment Market Size by Country (2021-2026) Table 95. South America, Middle East & Africa Overactive Bladder Treatment Market Size by Country (2027-2032) Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Overactive Bladder Treatment Product Image Figure 2. Global Overactive Bladder Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Overactive Bladder Treatment Market Share by Type: 2025 VS 2032 Figure 4. Drugs Image Figure 5. Device Image Figure 6. Global Overactive Bladder Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Overactive Bladder Treatment Market Share by Application: 2025 VS 2032 Figure 8. Idiopathic Overactive Bladder Image Figure 9. Neurogenic Overactive Bladder Image Figure 10. Global Overactive Bladder Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 12. Global Overactive Bladder Treatment Market Share by Region: 2025 VS 2032 Figure 13. Years Considered Figure 14. Global Overactive Bladder Treatment Market Share by Players in 2025 Figure 15. Global Top 5 and 10 Overactive Bladder Treatment Players Market Share by Revenue in 2025 Figure 16. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Overactive Bladder Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Overactive Bladder Treatment Revenue Market Share by Type (2021-2032) Figure 19. Global Overactive Bladder Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Overactive Bladder Treatment Revenue Market Share by Application (2021-2032) Figure 21. North America Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 22. North America Overactive Bladder Treatment Market Share by Type (2021-2032) Figure 23. North America Overactive Bladder Treatment Market Share by Application (2021-2032) Figure 24. North America Overactive Bladder Treatment Market Share by Country (2021-2032) Figure 25. United States Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 26. Canada Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 27. Mexico Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 28. Europe Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Europe Overactive Bladder Treatment Market Share by Type (2021-2032) Figure 30. Europe Overactive Bladder Treatment Market Share by Application (2021-2032) Figure 31. Europe Overactive Bladder Treatment Market Share by Country (2021-2032) Figure 32. Germany Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 33. France Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 34. U.K. Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 35. Italy Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 36. Russia Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 37. Nordic Countries Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 38. China Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 39. China Overactive Bladder Treatment Market Share by Type (2021-2032) Figure 40. China Overactive Bladder Treatment Market Share by Application (2021-2032) Figure 41. Asia Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 42. Asia Overactive Bladder Treatment Market Share by Type (2021-2032) Figure 43. Asia Overactive Bladder Treatment Market Share by Application (2021-2032) Figure 44. Asia Overactive Bladder Treatment Market Share by Country (2021-2032) Figure 45. Japan Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 46. South Korea Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 47. Taiwan Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 48. Southeast Asia Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 49. India Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Australia Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 51. South America, Middle East & Africa Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Overactive Bladder Treatment Market Share by Type (2021-2032) Figure 53. South America, Middle East & Africa Overactive Bladder Treatment Market Share by Application (2021-2032) Figure 54. South America, Middle East & Africa Overactive Bladder Treatment Market Share by Country (2021-2032) Figure 55. Brazil Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 56. South Africa Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 58. Turkey Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Argentina Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 60. UAE Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Egypt Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Chile Overactive Bladder Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Research Process Figure 64. Key Executives Interviewed

Scope & coverage.

Types
  • Drugs
  • Device
Applications
  • Idiopathic Overactive Bladder
  • Neurogenic Overactive Bladder
Companies covered
  • Allergan
  • Astellas Pharma
  • Pfizer
  • Johnson & Johnson
  • Medtronic
  • KYORIN Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Overactive Bladder Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Drugs
  5. 1.2.3 Device
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Overactive Bladder Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Idiopathic Overactive Bladder
  9. 1.3.3 Neurogenic Overactive Bladder
  10. 1.4 Global Market Growth Prospects
  11. 1.5 Global Overactive Bladder Treatment Growth Trends by Region
  12. 1.5.1 Global Overactive Bladder Treatment Market Size by Region: 2021 VS 2025 VS 2032
  13. 1.5.2 Overactive Bladder Treatment Market Size by Region (2021-2026)
  14. 1.5.3 Overactive Bladder Treatment Market Size by Region (2027-2032)
  15. 1.6 Assumptions and Limitations
  16. 1.7 Study Goals and Objectives
  17. 1.8 Years Considered
2 Global Overactive Bladder Treatment Market Dynamics
  1. 2.1 Overactive Bladder Treatment Industry Trends
  2. 2.2 Overactive Bladder Treatment Industry Drivers
  3. 2.3 Overactive Bladder Treatment Industry Opportunities and Challenges
  4. 2.4 Overactive Bladder Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Overactive Bladder Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Overactive Bladder Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Overactive Bladder Treatment Key Company Head office and Area Served
  4. 3.4 Global Overactive Bladder Treatment Company, Product Type & Application
  5. 3.5 Global Overactive Bladder Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Overactive Bladder Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Overactive Bladder Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Overactive Bladder Treatment Tier 1, Tier 2, and Tier 3
4 Overactive Bladder Treatment Market by Type
  1. 4.1 Global Overactive Bladder Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Overactive Bladder Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Overactive Bladder Treatment Market Size Share by Type (2021-2032)
5 Overactive Bladder Treatment Market by Application
  1. 5.1 Global Overactive Bladder Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Overactive Bladder Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Overactive Bladder Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Allergan
  2. 6.1.1 Allergan Company Information
  3. 6.1.2 Allergan Business Overview
  4. 6.1.3 Allergan Overactive Bladder Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Allergan Overactive Bladder Treatment Product Portfolio
  6. 6.1.5 Allergan Recent Developments
  7. 6.2 Astellas Pharma
  8. 6.2.1 Astellas Pharma Company Information
  9. 6.2.2 Astellas Pharma Business Overview
  10. 6.2.3 Astellas Pharma Overactive Bladder Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Astellas Pharma Overactive Bladder Treatment Product Portfolio
  12. 6.2.5 Astellas Pharma Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Overactive Bladder Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Pfizer Overactive Bladder Treatment Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Johnson & Johnson
  20. 6.4.1 Johnson & Johnson Company Information
  21. 6.4.2 Johnson & Johnson Business Overview
  22. 6.4.3 Johnson & Johnson Overactive Bladder Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Johnson & Johnson Overactive Bladder Treatment Product Portfolio
  24. 6.4.5 Johnson & Johnson Recent Developments
  25. 6.5 Medtronic
  26. 6.5.1 Medtronic Company Information
  27. 6.5.2 Medtronic Business Overview
  28. 6.5.3 Medtronic Overactive Bladder Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Medtronic Overactive Bladder Treatment Product Portfolio
  30. 6.5.5 Medtronic Recent Developments
  31. 6.6 KYORIN Pharmaceutical
  32. 6.6.1 KYORIN Pharmaceutical Company Information
  33. 6.6.2 KYORIN Pharmaceutical Business Overview
  34. 6.6.3 KYORIN Pharmaceutical Overactive Bladder Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 KYORIN Pharmaceutical Overactive Bladder Treatment Product Portfolio
  36. 6.6.5 KYORIN Pharmaceutical Recent Developments
7 North America
  1. 7.1 North America Overactive Bladder Treatment Market Size (2021-2032)
  2. 7.2 North America Overactive Bladder Treatment Market Size by Type
  3. 7.2.1 North America Overactive Bladder Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Overactive Bladder Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Overactive Bladder Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Overactive Bladder Treatment Market Size by Application
  7. 7.3.1 North America Overactive Bladder Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Overactive Bladder Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Overactive Bladder Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Overactive Bladder Treatment Market Size by Country
  11. 7.4.1 North America Overactive Bladder Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Overactive Bladder Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Overactive Bladder Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Overactive Bladder Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Overactive Bladder Treatment Market Size (2021-2032)
  2. 8.2 Europe Overactive Bladder Treatment Market Size by Type
  3. 8.2.1 Europe Overactive Bladder Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Overactive Bladder Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Overactive Bladder Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Overactive Bladder Treatment Market Size by Application
  7. 8.3.1 Europe Overactive Bladder Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Overactive Bladder Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Overactive Bladder Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Overactive Bladder Treatment Market Size by Country
  11. 8.4.1 Europe Overactive Bladder Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Overactive Bladder Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Overactive Bladder Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Overactive Bladder Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Overactive Bladder Treatment Market Size (2021-2032)
  2. 9.2 China Overactive Bladder Treatment Market Size by Type
  3. 9.2.1 China Overactive Bladder Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Overactive Bladder Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Overactive Bladder Treatment Market Share by Type (2021-2032)
  6. 9.3 China Overactive Bladder Treatment Market Size by Application
  7. 9.3.1 China Overactive Bladder Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Overactive Bladder Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Overactive Bladder Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Overactive Bladder Treatment Market Size (2021-2032)
  2. 10.2 Asia Overactive Bladder Treatment Market Size by Type
  3. 10.2.1 Asia Overactive Bladder Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Overactive Bladder Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Overactive Bladder Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Overactive Bladder Treatment Market Size by Application
  7. 10.3.1 Asia Overactive Bladder Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Overactive Bladder Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Overactive Bladder Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Overactive Bladder Treatment Market Size by Country
  11. 10.4.1 Asia Overactive Bladder Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Overactive Bladder Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Overactive Bladder Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Overactive Bladder Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Overactive Bladder Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Overactive Bladder Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Overactive Bladder Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Overactive Bladder Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Overactive Bladder Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Overactive Bladder Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Overactive Bladder Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Overactive Bladder Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Overactive Bladder Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Overactive Bladder Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Overactive Bladder Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Overactive Bladder Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Overactive Bladder Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Overactive Bladder Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst